Title:
LIVE BIOTHERAPEUTICS TO TREAT AND PREVENT LUNG CONDITIONS
Document Type and Number:
WIPO Patent Application WO/2020/081742
Kind Code:
A3
Abstract:
Methods and compositions are described for treatment of lung conditions using live biotherapeutics, in particular modified microbes, such as chimeric microbial hybrids or microbial mutants produced by environmental selective pressure and screened for characteristics that are therapeutically beneficial for treatment or prevention of lung conditions.
Inventors:
CANN ANTHONY F (US)
MUCHA JEANETTE M (US)
TOWNSEND STACY M (US)
TWOMEY DERIK A (US)
GOVONI GREGORY (US)
MUCHA JEANETTE M (US)
TOWNSEND STACY M (US)
TWOMEY DERIK A (US)
GOVONI GREGORY (US)
Application Number:
PCT/US2019/056617
Publication Date:
June 04, 2020
Filing Date:
October 16, 2019
Export Citation:
Assignee:
SCIBAC INC (US)
International Classes:
A61K35/74; C12N1/36; C12N15/01
Domestic Patent References:
| WO2018149904A1 | 2018-08-23 | |||
| WO2017087429A1 | 2017-05-26 | |||
| WO1993010815A1 | 1993-06-10 |
Foreign References:
| US20070190076A1 | 2007-08-16 |
Other References:
ZWICKER, C ET AL.: "Prophylactic and therapeutic inhibition of allergic airway inflammation by probiotic Escherichia coli 083", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 142, no. 6, 17 August 2018 (2018-08-17), pages 1 - 3, XP085549841
Attorney, Agent or Firm:
JACOBSON, Jill A. (US)
Download PDF: